Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Fulton F. Velez"'
Autor:
Fulton F. Velez, Daniel C. Malone
Publikováno v:
Journal of Market Access & Health Policy, Vol 9, Iss 1 (2021)
The lack of adequate treatment for many patients with opioid use disorder (OUD) has led to high medical costs ($90B in 2020). An analysis of the cost-effectiveness (cost-utility) of reSET-O, the first and only FDA-approved prescription digital therap
Externí odkaz:
https://doaj.org/article/67822499b65b4ffd963421fc70fcd299
Autor:
Felicia Forma, Tyler G Knight, Frances P Thorndike, Xiaorui Xiong, Rebecca Baik, Fulton F Velez, Yuri A Maricich, Daniel C Malone
Publikováno v:
ClinicoEconomics and Outcomes Research. 14:537-546
Felicia Forma,1 Tyler G Knight,2 Frances P Thorndike,1 Xiaorui Xiong,1 Rebecca Baik,2 Fulton F Velez,1 Yuri A Maricich,1 Daniel C Malone3 1Pear Therapeutics, Inc., Medical Affairs Department, Boston, MA, USA; 2Labcorp Drug Development, Market Access
Autor:
Neel Shah, Fulton F. Velez, Samuel Colman, Laura Kauffman, Charles Ruetsch, Kathryn Anastassopoulos, Yuri Maricich
Publikováno v:
Advances in Therapy. 39:4146-4156
Autor:
Fulton F. Velez, Kathryn P. Anastassopoulos, Samuel Colman, Neel Shah, Laura Kauffman, Sean M. Murphy, Charles Ruetsch, Yuri A. Maricich
Publikováno v:
Advances in Therapy. 39:4131-4145
reSET-O, an FDA-authorized prescription digital therapeutic (PDT) delivering cognitive behavioral therapy and contingency management to patients with opioid uRetrospective analysis of healthcare claims data compared all-cause HCRU (across hospital fa
Publikováno v:
CNS Spectrums. 28:228-228
IntroductionreSET-O® is an FDA-authorized prescription digital therapeutic (PDT) for opioid use disorder (OUD) providing cognitive behavioral therapy as an adjunct to buprenorphine therapy. This analysis describes differences in inpatient hospitaliz
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 22(4)
Opioid use disorder (OUD) is associated with high healthcare resource utilization (HCRU) and costs. reSET-O is an FDA-cleared prescription digital therapeutic that delivers neurobehavioral therapy as an adjunct to treatment-as-usual (TAU; buprenorphi
Autor:
Joseph J. Medicis, Emmanuel M. Mahlis, Nate J. Smith, Rachel Beckerman, Joseph Gricar, John C. Messina, Fulton F. Velez, Ramy A. Mahmoud
Publikováno v:
Journal of Allergy and Clinical Immunology. 141:AB165
Autor:
Forma F; Pear Therapeutics (US), Inc, Boston, MA, USA., Pratiwadi R; Maple Health Group, LLC, New York, NY, USA., El-Moustaid F; Maple Health Group, LLC, New York, NY, USA., Smith N; Maple Health Group, LLC, New York, NY, USA., Thorndike F; Pear Therapeutics (US), Inc, Boston, MA, USA., Velez F; Pear Therapeutics (US), Inc, Boston, MA, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2022 Oct; Vol. 38 (10), pp. 1727-1738. Date of Electronic Publication: 2022 Aug 23.
Autor:
Maricich YA; Pear Therapeutics Inc., Boston, MA, USA., Xiong X; Pear Therapeutics Inc., Boston, MA, USA., Gerwien R; Pear Therapeutics Inc., Boston, MA, USA., Kuo A; Pear Therapeutics Inc., Boston, MA, USA., Velez F; Pear Therapeutics Inc., Boston, MA, USA., Imbert B; Pear Therapeutics Inc., Boston, MA, USA., Boyer K; Pear Therapeutics Inc., Boston, MA, USA., Luderer HF; Pear Therapeutics Inc., Boston, MA, USA., Braun S; Pear Therapeutics Inc., Boston, MA, USA., Williams K; Pear Therapeutics Inc., Boston, MA, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2021 Feb; Vol. 37 (2), pp. 175-183. Date of Electronic Publication: 2020 Dec 07.
Autor:
Divino V; IMS Health, 8280 Willow Oaks Corporate Drive, Suite 775, Fairfax 22031, VA, USA. Electronic address: vdivino@us.imshealth.com., Petrilla AA; IMS Health, 8280 Willow Oaks Corporate Drive, Suite 775, Fairfax 22031, VA, USA., Bollu V; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough 01752, MA, USA., Velez F; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough 01752, MA, USA., Ettinger A; Albert Einstein College of Medicine, Neurological Surgery, PC, 1991 Marcus Avenue, Suite 108, Lake Success 11042, NY, USA., Makin C; IMS Health, 8280 Willow Oaks Corporate Drive, Suite 775, Fairfax 22031, VA, USA.
Publikováno v:
Epilepsy & behavior : E&B [Epilepsy Behav] 2015 Oct; Vol. 51, pp. 40-7. Date of Electronic Publication: 2015 Aug 05.